Pharmac Proposes To Widen Access To Medicine Used In The Treatment Of Heart Failure
Pharmac is consulting on plans to widen access to empagliflozin, a medicine used in the treatment of chronic heart failure that would benefit more than 18,000 people in the first year of funding.